These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 33740892)

  • 1. The efficacy and safety of itopride in feeding intolerance of critically ill patients receiving enteral nutrition: a randomized, double-blind study.
    Elmokadem EM; El Borolossy RM; Bassiouny AM; Hanna MG; Darweesh EAG; Sabri NA
    BMC Gastroenterol; 2021 Mar; 21(1):126. PubMed ID: 33740892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, randomized, double-blind study of ulimorelin and metoclopramide in the treatment of critically ill patients with enteral feeding intolerance: PROMOTE trial.
    Heyland DK; van Zanten ARH; Grau-Carmona T; Evans D; Beishuizen A; Schouten J; Hoiting O; Bordejé ML; Krell K; Klein DJ; Gonzalez J; Perez A; Brown R; James J; Harris MS;
    Intensive Care Med; 2019 May; 45(5):647-656. PubMed ID: 31062046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of prokinetic agents in critically ill patients receiving enteral nutrition: a systematic review and meta-analysis of randomized trials.
    Lewis K; Alqahtani Z; Mcintyre L; Almenawer S; Alshamsi F; Rhodes A; Evans L; Angus DC; Alhazzani W
    Crit Care; 2016 Aug; 20(1):259. PubMed ID: 27527069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acupuncture in critically ill patients improves delayed gastric emptying: a randomized controlled trial.
    Pfab F; Winhard M; Nowak-Machen M; Napadow V; Irnich D; Pawlik M; Bein T; Hansen E
    Anesth Analg; 2011 Jan; 112(1):150-5. PubMed ID: 21081772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blinded, Double-Dummy, Parallel-Group, Phase 2a Randomized Clinical Trial to Evaluate the Efficacy and Safety of a Highly Selective 5-Hydroxytryptamine Type 4 Receptor Agonist in Critically Ill Patients With Enteral Feeding Intolerance.
    Chapman MJ; Jones KL; Almansa C; Barnes CN; Nguyen D; Deane AM
    JPEN J Parenter Enteral Nutr; 2021 Jan; 45(1):115-124. PubMed ID: 31990087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Enteral Erythromycin Estolate in Combination With Intravenous Metoclopramide vs Intravenous Metoclopramide Monotherapy in Mechanically Ventilated Patients With Enteral Feeding Intolerance: A Randomized, Double-Blind, Controlled Pilot Study.
    Charoensareerat T; Bhurayanontachai R; Sitaruno S; Navasakulpong A; Boonpeng A; Lerkiatbundit S; Pattharachayakul S
    JPEN J Parenter Enteral Nutr; 2021 Aug; 45(6):1309-1318. PubMed ID: 32895971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prokinetic therapy for feed intolerance in critical illness: one drug or two?
    Nguyen NQ; Chapman M; Fraser RJ; Bryant LK; Burgstad C; Holloway RH
    Crit Care Med; 2007 Nov; 35(11):2561-7. PubMed ID: 17828038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Domperidone Administered via Feeding Tube and Feeding Success in Critically Ill Patients with Enteral Feeding Intolerance.
    Cheng Y; Chen C; Yang H; Fu M; Zhong X; Wang B; Hu Z; He M; Zhang Z; Jin X; Kang Y; Wu Q
    J Pers Med; 2021 Aug; 11(9):. PubMed ID: 34575623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combined prokinetic administration on gastric emptying in critically ill patients.
    Baradari AG; Khajavi MR; Firouzian A; Alipour A; Daneshpour H; Panahi Y; Sahebkar A
    Arab J Gastroenterol; 2017 Mar; 18(1):30-34. PubMed ID: 28262529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the effect of oral synbiotic on enteral feeding tolerance in critically ill patients: A double-blinded controlled clinical trial of gut microbiota.
    Dehghani MH; Saghafi F; Bordbari Z; Zare-Kamali J; Jafari-Nedooshan J; Sahebnasagh A
    Nutr Clin Pract; 2023 Apr; 38(2):402-410. PubMed ID: 35809224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled feasibility and proof-of-concept trial in delayed gastric emptying when metoclopramide fails: We should revisit nasointestinal feeding versus dual prokinetic treatment: Achieving goal nutrition in critical illness and delayed gastric emptying: Trial of nasointestinal feeding versus nasogastric feeding plus prokinetics.
    Taylor SJ; Allan K; McWilliam H; Manara A; Brown J; Greenwood R; Toher D
    Clin Nutr ESPEN; 2016 Aug; 14():1-8. PubMed ID: 28531392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fat-Modified Enteral Formula Improves Feeding Tolerance in Critically Ill Patients: A Multicenter, Single-Blind, Randomized Controlled Trial.
    Qiu C; Chen C; Zhang W; Kou Q; Wu S; Zhou L; Liu J; Ma G; Chen J; Chen M; Luo H; Zhang X; Lai J; Yu Z; Yu X; Liao W; Guan X; Ouyang B
    JPEN J Parenter Enteral Nutr; 2017 Jul; 41(5):785-795. PubMed ID: 26350918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Double-Blind Randomized Clinical Trial Comparing the Effect of Neostigmine and Metoclopramide on Gastric Residual Volume of Mechanically Ventilated ICU Patients.
    Gholipour Baradari A; Alipour A; Firouzian A; Moarab L; Emami Zeydi A
    Acta Inform Med; 2016 Dec; 24(6):385-389. PubMed ID: 28077899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Daikenchuto for Mechanically Ventilated Patients With Enteral Feeding Intolerance: A Propensity Score-Matched Analysis Using a Nationwide Administrative Inpatient Database.
    Ohbe H; Jo T; Matsui H; Fushimi K; Yasunaga H
    JPEN J Parenter Enteral Nutr; 2021 Nov; 45(8):1703-1713. PubMed ID: 33483948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of prokinetics in critically ill adults receiving gastric feeding tubes: A systematic review and meta-analysis.
    Peng R; Li H; Yang L; Zeng L; Yi Q; Xu P; Pan X; Zhang L
    PLoS One; 2021; 16(1):e0245317. PubMed ID: 33428672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of continuous versus intermittent enteral nutrition in critically ill patients (COINN): study protocol for a randomized comparative effectiveness trial.
    Hrdy O; Vrbica K; Strazevska E; Suk P; Souckova L; Stepanova R; Sas I; Gal R
    Trials; 2020 Nov; 21(1):955. PubMed ID: 33228772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness.
    Nguyen NQ; Chapman MJ; Fraser RJ; Bryant LK; Holloway RH
    Crit Care Med; 2007 Feb; 35(2):483-9. PubMed ID: 17205032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new high protein-to-energy enteral formula with a whey protein hydrolysate to achieve protein targets in critically ill patients: a prospective observational tolerability study.
    Tedeschi-Jockers F; Reinhold S; Hollinger A; Tuchscherer D; Kiss C; Gantner L; Ledergerber K; Zimmermann S; Scheuzger J; Huber J; Siegemund M
    Eur J Clin Nutr; 2022 Mar; 76(3):419-427. PubMed ID: 34168292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of gastrointestinal tolerance to two enteral feeding protocols in critically ill patients: a prospective, randomized controlled trial.
    Pinilla JC; Samphire J; Arnold C; Liu L; Thiessen B
    JPEN J Parenter Enteral Nutr; 2001; 25(2):81-6. PubMed ID: 11284474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric residual volume in critically ill patients: a dead marker or still alive?
    Elke G; Felbinger TW; Heyland DK
    Nutr Clin Pract; 2015 Feb; 30(1):59-71. PubMed ID: 25524884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.